Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Dipti Talaulikar; Ranjana H Advani; Andrew R Branagan; Christian Buske; Meletios A Dimopoulos; Shirley D'Sa; Maria J Kersten; Veronique Leblond; Monique C Minnema; Roger G Owen; Maria Lia Palomba; Alessandra Tedeschi; Judith Trotman; Marzia Varettoni; Josephine M Vos; Steven P Treon; Efstathios Kastritis; Jorge J Castillo

doi:10.1097/HS9.0000000000000433

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Dipti Talaulikar
, Ranjana H Advani
, Andrew R Branagan
, Christian Buske
, Meletios A Dimopoulos
, Shirley D'Sa
, Maria J Kersten
, Veronique Leblond
, Monique C Minnema
, Roger G Owen
, Maria Lia Palomba
, Alessandra Tedeschi
, Judith Trotman
, Marzia Varettoni
, Josephine M Vos
, Steven P Treon
, Efstathios Kastritis
, Jorge J Castillo

Australian National University
Stanford University Medical Center
Harvard Medical School Boston: Massachusetts General Hospital
University Hospital Medical Center, Ulm, Germany
National and Kapodistrian University of Athens
University College London Hospitals NHS Foundation Trust
Department of Sciences, Amsterdam University College, VU Amsterdam/University of Amsterdam, 1012 WX, Amsterdam, The Netherlands
Sorbonne University Abu Dhabi
Van Creveldkliniek, University Medical Center Utrecht, University Utrecht, Utrecht.
St James’s University Hospital
Department of Healthcare Policy and Research, Weill Cornell Medical College, Cornell University, New York, NY, USA.
Niguarda Cancer Center, Grande Ospedale Metropolitano Niguarda, Milan, Italy
Sydney School of Public Health, The University of Sydney, Sydney, New South Wales, Australia [email protected].
IRCCS Fondazione Policlinico San Matteo - Pavia
Dana-Farber Cancer Institute

Research output: Contribution to journal › Review article › Academic › peer-review

20 Downloads (Pure)

Abstract

In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

Original language	English
Pages (from-to)	e433
Journal	HemaSphere
Volume	4
Issue number	4
DOIs	https://doi.org/10.1097/HS9.0000000000000433
Publication status	Published - Aug 2020

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1097/HS9.0000000000000433

Consensus-statement-on-the-management-of-waldenstrom-macroglobulinemia-patients-during-the-covid-19-pandemic.pdfFinal published version, 199 KB

Cite this

Talaulikar, D., Advani, R. H., Branagan, A. R., Buske, C., Dimopoulos, M. A., D'Sa, S., Kersten, M. J., Leblond, V., Minnema, M. C., Owen, R. G., Palomba, M. L., Tedeschi, A., Trotman, J., Varettoni, M., Vos, J. M., Treon, S. P., Kastritis, E., & Castillo, J. J. (2020). Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic. HemaSphere, 4(4), e433. https://doi.org/10.1097/HS9.0000000000000433

@article{459523f8574f4b4b9eb88e951ad7d57e,

title = "Consensus Statement on the Management of Waldenstr{\"o}m Macroglobulinemia Patients During the COVID-19 Pandemic",

abstract = "In the light of the COVID-19 pandemic, the International Workshop on Waldenstr{\"o}m Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenstr{\"o}m Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.",

author = "Dipti Talaulikar and Advani, \{Ranjana H\} and Branagan, \{Andrew R\} and Christian Buske and Dimopoulos, \{Meletios A\} and Shirley D'Sa and Kersten, \{Maria J\} and Veronique Leblond and Minnema, \{Monique C\} and Owen, \{Roger G\} and Palomba, \{Maria Lia\} and Alessandra Tedeschi and Judith Trotman and Marzia Varettoni and Vos, \{Josephine M\} and Treon, \{Steven P\} and Efstathios Kastritis and Castillo, \{Jorge J\}",

note = "Copyright {\textcopyright} 2020 the Author(s). Published by Wolters Kluwer Health, Inc. on behalf of the European Hematology Association.",

year = "2020",

month = aug,

doi = "10.1097/HS9.0000000000000433",

language = "English",

volume = "4",

pages = "e433",

journal = "HemaSphere",

issn = "2572-9241",

publisher = "John Wiley and Sons Inc.",

number = "4",

}

Talaulikar, D, Advani, RH, Branagan, AR, Buske, C, Dimopoulos, MA, D'Sa, S, Kersten, MJ, Leblond, V, Minnema, MC, Owen, RG, Palomba, ML, Tedeschi, A, Trotman, J, Varettoni, M, Vos, JM, Treon, SP, Kastritis, E & Castillo, JJ 2020, 'Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic', HemaSphere, vol. 4, no. 4, pp. e433. https://doi.org/10.1097/HS9.0000000000000433

TY - JOUR

T1 - Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

AU - Talaulikar, Dipti

AU - Advani, Ranjana H

AU - Branagan, Andrew R

AU - Buske, Christian

AU - Dimopoulos, Meletios A

AU - D'Sa, Shirley

AU - Kersten, Maria J

AU - Leblond, Veronique

AU - Minnema, Monique C

AU - Owen, Roger G

AU - Palomba, Maria Lia

AU - Tedeschi, Alessandra

AU - Trotman, Judith

AU - Varettoni, Marzia

AU - Vos, Josephine M

AU - Treon, Steven P

AU - Kastritis, Efstathios

AU - Castillo, Jorge J

PY - 2020/8

Y1 - 2020/8

N2 - In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

AB - In the light of the COVID-19 pandemic, the International Workshop on Waldenström Macroglobulinemia (IWWM) Treatment Recommendations Panel felt the need to provide a consensus statement for the management of Waldenström Macroglobulinemia (WM) patients during this challenging time. We followed the current recommendations by the American Society of Hematology, which have been modified accordingly to fit the specific realities associated with the management of WM. In this Consensus Statement, the Panel addresses questions related to treatment initiation, preferred therapies, minimizing visit to clinics and infusions centers, supportive care and guidance for WM patients in clinical trials. Finally, we also provide information on timing and appropriateness of testing and management of COVID-19 infected patients, as well as ways to get physicians and patients involved in registry studies that could help others.

U2 - 10.1097/HS9.0000000000000433

DO - 10.1097/HS9.0000000000000433

M3 - Review article

SN - 2572-9241

VL - 4

SP - e433

JO - HemaSphere

JF - HemaSphere

IS - 4

ER -

Consensus Statement on the Management of Waldenström Macroglobulinemia Patients During the COVID-19 Pandemic

Abstract

UN SDGs

Access to Document

Fingerprint

Cite this